 PHILADELPHIA, Sept. 03, 2021 GLOBE NEWSWIRE -- AnPac Bio-Medical Science Co., Ltd. AnPac Bio, the Company or we NASDAQ: ANPC, a biotechnology company with operations in the United States and China, today announced that its subsidiary, Anpac Bio-Medical Science Lishui Co., Ltd. has increased its holding in one of its subsidiaries AnPai Shanghai Healthcare Management Consultant Co., Ltd. AnPai with approvals by its audit committee and board of directors. The company has carried out rigorous due diligence including financial and legal audits, as well as appraisals by a qualified appraiser. The company completed the share structure registration amendment with the local Administration Management Bureau in late August 2021. 